ML-SYS / 2026.07NON-CLINICAL RESEARCH MATERIALSORIGIN DECLARED BY LOT

← Compound index

RM-TRS / Tissue, repair and matrix signalling

Palmitoyl Hexapeptide-12

Also known as: Biopeptide EL · Lipopeptide · Pal-VGVAPG · Palmitoyl Oligopeptide

Related-compound evidence onlyEvidence grade D: Related-compound evidence only

Grade describes the published research on the molecule. It is not a quality score, a safety score, or a release state.

What this is

Palmitoyl hexapeptide-12 is Pal-VGVAPG. The word lipopeptide describes a broad class and is not an adequate material name on its own.

Evidence position

The exact chemical identity is clear, but market labels are inconsistent and the independent human record for the isolated ingredient is weak. The entry is Grade D.

What the record does not establish

A generic Lipopeptide label does not establish Pal-VGVAPG, Pal-GQPR or GHK-Cu. Sequence, formula, mass and lot-specific analysis must agree.

Sources

  • 01
    Palmitoyl Hexapeptide-12 compound recordPubChem
    Shows
    Registry structure, formula and Pal-VGVAPG sequence
    Does not show
    Chemical identity does not establish performance or lot quality
  • 02
    VGVAPG parent-peptide recordPubChem
    Shows
    Identity of the non-palmitoylated VGVAPG hexapeptide
    Does not show
    Parent-peptide evidence does not automatically transfer to the palmitoylated derivative
  • 03
    Conflicted Lipopeptide market listingCore Peptides
    Shows
    A live market page that labels the contents as GHK-Cu, describes Pal-GQPR, and lists the Pal-VGVAPG formula
    Does not show
    The internal inconsistency is evidence that the generic market label is unsafe for identity assignment

External database index

LIVE DATABASE INDEX / SEPARATE FROM CURATED EVIDENCE

Records below come directly from public scientific databases. They help find relevant material, but do not affect the evidence grade until they are matched to the molecule and added to the curated source list.

Related compounds